Microfluidic Chip Sequencing Using Magnetic Trapping

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA sequencing technologies are inadequate for high-throughput, cost-effective sequencing of infinite genomes, including human, animal, plant, bacterial, and viral genomes, due to limitations in capacity and efficiency, especially with rapid viral mutation rates.

Innovation Solution

The method involves using microfluidic devices with magnetic nanoparticles or polystyrene beads to amplify and sequence nucleic acids within microreactors, utilizing a magnetic field to trap and isolate particles, allowing for efficient washing and reagent reduction, and enabling real-time detection and characterization of genetic material.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current electrophoresis technologies are used for DNA sequencing, then sequencing can be performed, but the capacity and efficiency are insufficient to handle the infinite genomes and rapid viral mutation rates

Engineering Contradiction:
Improvesequencing capacityVSAvoidsequencing efficiency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention divides the sequencing process into discrete microreactors containing individual nucleic acid molecules, each processed independently. This segmentation enables massive parallelization where thousands of sequences are processed simultaneously, dramatically increasing throughput capacity while maintaining high efficiency for each individual reaction.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Magnetic nanoparticles serve as intermediaries that bind to nucleic acid molecules, enabling their manipulation, isolation, and positioning within microreactors. These magnetic mediators allow for efficient washing, sorting, and concentration of nucleic acids without compromising reaction efficiency or requiring complex mechanical handling.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of time

If microfluidic devices with magnetic nanoparticles are used, then reagent volumes are reduced and processing speed increases, but device complexity increases

Engineering Contradiction:
Improveprocessing timeVSAvoidmicrofluidic system complexity
Core Design Contradiction:
Loss of timeVSDevice complexity

Solution Approach 1:

The invention replaces complex mechanical fluid handling systems with magnetic field-based manipulation. Instead of using pumps, valves, and mechanical actuators to move and position nucleic acids, magnetic fields act on magnetic nanoparticles to achieve the same functions, simplifying the device architecture while enabling rapid processing and reducing reagent volumes.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The magnetic nanoparticles serve multiple functions simultaneously: they act as carriers for nucleic acids, respond to magnetic fields for positioning and isolation, enable washing and purification, and facilitate detection. This multi-functionality reduces the need for separate components, thereby reducing overall device complexity despite the advanced capabilities.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If magnetic fields are used to trap particles in PCR/Sequencing Zone, then washing and reagent removal is improved, but energy consumption increases

Engineering Contradiction:
Improvewashing efficiencyVSAvoidmagnetic field energy
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The magnetic field is applied periodically rather than continuously - activated during trapping and washing phases, then deactivated or reduced during sequencing and between samples. This periodic application maintains effective washing and isolation while significantly reducing overall energy consumption compared to continuous magnetic field application.

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The invention extracts and removes excess reagents and washing buffers from the system while magnetic particles remain trapped in the sequencing zone. By taking out the liquid phase while maintaining the magnetic trap, efficient washing is achieved without requiring continuous energy input, as the magnetic field only needs to hold particles in place, not actively manipulate them during washing.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables fast, low-cost, and high-throughput DNA sequencing, reducing reagent volumes, processing times, and enhancing sensitivity, facilitating the detection of novel viruses and organisms, and scalable mass production of microfluidic analysis chips.

Implementation Method 1

amplification of the genetic material within microreactors, denaturing and demulsifying and then sequencing the material, while retaining it in the PCR/Sequencing Zone by a magnetic field

Methodology Applied
Scientific EffectMagnetic field: Magnetic Field

Implementation Method 2

amplifying the nucleic acids through PCR or isothermal amplification

Methodology Applied
Scientific EffectPolymerase chain reaction:

Data Source

PatentUS8815576B2Chip-based sequencing nucleic acids
Publication Date: 2014.08.26 LAWRENCE LIVERMORE NAT SECURITY LLC
  • US8815576B2 patent drawing
  • US8815576B2 patent drawing
  • US8815576B2 patent drawing

AI summary

A system for fast DNA sequencing by amplification of genetic material within microreactors, denaturing, demulsifying, and then sequencing the material, while retaining it in a PCR/sequencing zone by a magnetic field. One embodiment includes sequencing nucleic acids on a microchip that includes a microchannel flow channel in the microchip. The nucleic acids are isolated and hybridized to magnetic nanoparticles or to magnetic polystyrene-coated beads. Microreactor droplets are formed in the microchannel flow channel. The microreactor droplets containing the nucleic acids and the magnetic nanoparticles are retained in a magnetic trap in the microchannel flow channel and sequenced.